Alberto Aimo

8.8k total citations · 2 hit papers
225 papers, 4.4k citations indexed

About

Alberto Aimo is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Alberto Aimo has authored 225 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Cardiology and Cardiovascular Medicine, 83 papers in Molecular Biology and 36 papers in Nephrology. Recurrent topics in Alberto Aimo's work include Amyloidosis: Diagnosis, Treatment, Outcomes (66 papers), Cardiovascular Function and Risk Factors (51 papers) and Heart Failure Treatment and Management (45 papers). Alberto Aimo is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (66 papers), Cardiovascular Function and Risk Factors (51 papers) and Heart Failure Treatment and Management (45 papers). Alberto Aimo collaborates with scholars based in Italy, Spain and United Kingdom. Alberto Aimo's co-authors include Michele Emdin, Giuseppe Vergaro, Claudio Passino, Vincenzo Castiglione, Andrea Barison, Luigi Francesco Saccaro, Alberto Giannoni, Antoni Bayés‐Genís, Georgios Georgiopoulos and Claudio Rapezzi and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Alberto Aimo

202 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biomarkers for the diagnosis and management of heart failure

2021 255 citations Vincenzo Castiglione, Alberto Aimo et al. Heart Failure Reviews profile →
RNA-targeting and gene editing therapies for transthyretin amyloidosis

2022 120 citations Alberto Aimo, Vincenzo Castiglione et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alberto Aimo Italy	34	2.3k	1.5k	551	545	465	225	4.4k
Celestino Sardu Italy	48	1.9k 0.8×	1.4k 0.9×	956 1.7×	315 0.6×	131 0.3×	132	5.6k
Κimon Stamatelopoulos Greece	36	1.5k 0.7×	824 0.6×	421 0.8×	353 0.6×	119 0.3×	166	4.2k
Kenjiro Kikuchi Japan	33	1.6k 0.7×	1.1k 0.7×	694 1.3×	375 0.7×	417 0.9×	264	4.3k
Jianzeng Dong China	35	3.6k 1.5×	713 0.5×	681 1.2×	281 0.5×	95 0.2×	442	5.5k
Benjamín W. Van Tassell United States	40	3.0k 1.3×	3.1k 2.1×	1.3k 2.3×	297 0.5×	328 0.7×	80	6.1k
Hwee Teoh Canada	39	1.9k 0.8×	1.8k 1.2×	1.3k 2.3×	314 0.6×	105 0.2×	151	5.9k
Jian Zhang China	33	1.7k 0.7×	1.6k 1.1×	474 0.9×	536 1.0×	95 0.2×	228	4.5k
Ashour Michael Italy	29	1.0k 0.4×	1.6k 1.1×	391 0.7×	228 0.4×	754 1.6×	68	3.5k
Giuseppe Vergaro Italy	33	1.9k 0.8×	1.5k 1.0×	393 0.7×	456 0.8×	593 1.3×	169	3.6k
Yukio Maruyama Japan	37	1.7k 0.7×	1.9k 1.3×	972 1.8×	202 0.4×	682 1.5×	293	5.8k

Countries citing papers authored by Alberto Aimo

Since Specialization

Citations

This map shows the geographic impact of Alberto Aimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Aimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Aimo more than expected).

Fields of papers citing papers by Alberto Aimo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Aimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Aimo. The network helps show where Alberto Aimo may publish in the future.

Co-authorship network of co-authors of Alberto Aimo

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Aimo. A scholar is included among the top collaborators of Alberto Aimo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Aimo. Alberto Aimo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garibaldi, Silvia, Alberto Aimo, Giovanni Concistrè, et al.. (2025). Extravascular implantable cardioverter-defibrillator implantation in a teenager with Brugada syndrome and recurrent inappropriate shocks of subcutaneous implantable cardioverter-defibrillator. HeartRhythm Case Reports. 11(12). 1343–1348.

Vergaro, Giuseppe, Adam Ioannou, Giorgia Panichella, et al.. (2025). Current and emerging treatment options for transthyretin amyloid cardiomyopathy. Heart. 112(3). 129–138.

Genovesi, Dario, Giuseppe Vergaro, Assuero Giorgetti, et al.. (2024). [18F]‐florbetaben PET/CT is sensitive for cardiac AL amyloidosis. European Journal of Clinical Investigation. 54(10). e14270–e14270. 1 indexed citations

Aimo, Alberto, Pau Codina, Matthew M.Y. Lee, & Daniela Tomasoni. (2024). What's New in Heart Failure? June–July 2024. European Journal of Heart Failure. 26(7). 1449–1453.

Aimo, Alberto, Pau Codina, Matthew M.Y. Lee, & Daniela Tomasoni. (2024). What's New in Heart Failure? May–June 2024. European Journal of Heart Failure. 26(6). 1273–1277.

Aimo, Alberto, Vincenzo Castiglione, Veronica Musetti, et al.. (2024). Rarefaction of Blood, But Not Lymphatic Capillaries, in Patients With Cardiac Amyloidosis. JACC CardioOncology. 6(5). 797–799. 1 indexed citations

Pascual‐Figal, Domingo A., Julio Núñez, Teresa Martı́nez, et al.. (2024). Colchicine in acutely decompensated heart failure: the COLICA trial. European Heart Journal. 45(45). 4826–4836. 20 indexed citations

Giannoni, Alberto, Alberto Aimo, Paolo Aretini, et al.. (2024). Whole-exome sequencing to identify causative variants in juvenile sudden cardiac death. Human Genomics. 18(1). 102–102. 3 indexed citations

Fusco, Stefania Angela Di, Alberto Aimo, Andrea Matteucci, et al.. (2023). Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico. Giornale italiano di cardiologia. 24(4). 323–331. 2 indexed citations

10.

Aimo, Alberto, Iacopo Fabiani, Giorgia Panichella, et al.. (2023). Valvular heart disease in patients with cardiac amyloidosis. Heart Failure Reviews. 29(1). 65–77. 14 indexed citations

11.

Rueda, Ferran, Cosme García‐García, Pau Codina, et al.. (2023). La proteína meteorin-like se asocia a un perfil de mayor riesgo y predice un peor pronóstico en pacientes con IAMCEST. Revista Española de Cardiología. 76(11). 891–900. 2 indexed citations

12.

Aimo, Alberto, Iacopo Fabiani, Pier Giorgio Masci, et al.. (2023). Magnetic resonance imaging for diagnostic workup of embolic stroke of undetermined source: A systematic review. International Journal of Stroke. 19(3). 293–304. 2 indexed citations

13.

Rapezzi, Claudio, Alberto Aimo, Andrea Barison, et al.. (2022). Restrictive cardiomyopathy: definition and diagnosis. European Heart Journal. 43(45). 4679–4693. 90 indexed citations

14.

Perrone, Marco Alfonso, Alberto Aimo, Sergio Bernardini, & Aldo Clerico. (2022). Natriuretic Peptides and Troponins to Predict Cardiovascular Events in Patients Undergoing Major Non-Cardiac Surgery. International Journal of Environmental Research and Public Health. 19(9). 5182–5182. 7 indexed citations

15.

Emdin, Michele, Federico Perfetto, Alberto Aimo, et al.. (2021). Percorso clinico-assistenziale in rete per la diagnosi e la gestione del paziente con amiloidosi cardiaca. Documento di consenso ANMCO Toscana e SIC Tosco-Umbra. Giornale italiano di cardiologia. 22(8). 621–634.

16.

Aimo, Alberto, et al.. (2021). Myocardial innervation imaging: MIBG in clinical practice. 13(2). 87–97. 1 indexed citations

17.

Castiglione, Vincenzo, Alberto Aimo, Nicoletta Botto, et al.. (2021). Molecular Autopsy of Sudden Cardiac Death in the Genomics Era. Diagnostics. 11(8). 1378–1378. 20 indexed citations

18.

Vergaro, Giuseppe, James L. Januzzi, Alain Cohen Solal, et al.. (2018). NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure. International Journal of Cardiology. 271. 324–330. 23 indexed citations

19.

Barison, Andrea, Alberto Aimo, Alessandro Ortalda, et al.. (2017). Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy. International Journal of Cardiology. 250. 195–200. 37 indexed citations

20.

Aspromonte, Nadia, Michele Massimo Gulizia, Aldo Clerico, et al.. (2016). Documento di consenso ANMCO/ELAS/SIBioC: Raccomandazioni sull’impiego dei biomarcatori cardiaci nello scompenso cardiaco. Giornale italiano di cardiologia. 17(9). 615–656. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact